Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Feb 12:2019:4615745.
doi: 10.1155/2019/4615745. eCollection 2019.

A Systematic Review of Potential Therapeutic Use of Lycium Barbarum Polysaccharides in Disease

Sum Sum Kwok  1 , Yashan Bu  1 , Amy Cheuk-Yin Lo  1 , Tommy Chung-Yan Chan  1   2 , Kwok Fai So  1 , Jimmy Shiu-Ming Lai  1 , Kendrick Co Shih  1
Affiliations

A Systematic Review of Potential Therapeutic Use of Lycium Barbarum Polysaccharides in Disease

Sum Sum Kwok et al. Biomed Res Int. .

Abstract

Objective: To evaluate the effect of Lycium barbarum polysaccharides in the treatment and/or prevention of diseases of different etiologies and systems.

Methods: We performed an Entrez PubMed literature search using keywords "lycium", "barbarum", "polysaccharides", "anti-fibrotic", "anti-apoptotic", "anti-oxidizing", "anti-aging", "neuroprotection", "metabolism", "diabetes", "hyperlipidemia", "neuroprotection", and "immunomodulation" on the 14th of August 2018, resulting in 207 papers, of which 20 were chosen after filtering for 'English language' and 'published within 10 years' as well as curation for relevance by the authors.

Results: The 20 selected papers included 2 randomized control trials (1 double-blinded RCT and 1 double-blinded placebo-controlled RCT), 11 in vivo studies, 5 in vitro studies, 1 study with both in vivo and in vitro results, and 1 chemical study. There is good evidence from existing studies on the antifibrotic, antioxidizing, neuroprotective, anticancer, and anti-inflammatory effects of Lycium barbarum polysaccharides. However, there is a need for further studies in the form of large-scale clinical trials to support its use in humans. There is also significant potential for LBP as a safe and effective topical treatment in ocular surface diseases, owing to promising in vitro results and a lack of demonstrated toxic effects to corneal epithelial cells.

Conclusion: Results from existing studies suggest that LBP is a promising therapeutic agent, particularly in the management of liver disease, hyperlipidemia, and diabetes. One major limitation of current research is a lack of standardization and quality control for the LBP used. The availability of research-grade LBP will inevitably promote future research in this field worldwide.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flowchart of search strategy.
See this image and copyright information in PMC

References

    1. Zhang M., Chen H., Huang J., Li Z., Zhu C., Zhang S. Effect of lycium barbarum polysaccharide on human hepatoma QGY7703 cells: inhibition of proliferation and induction of apoptosis. Life Sciences. 2005;76(18):2115–2124. doi: 10.1016/j.lfs.2004.11.009. - DOI - PubMed
    1. Potterat O. Goji (Lycium barbarum and L. chinense): phytochemistry, pharmacology and safety in the perspective of traditional uses and recent popularity. Planta Medica. 2010;76(1):7–19. doi: 10.1055/s-0029-1186218. - DOI - PubMed
    1. Chang R. C.-C., So K.-F. Use of anti-aging herbal medicine, Lycium barbarum, against aging-associated diseases. What do we know so far? Cellular and Molecular Neurobiology. 2008;28(5):643–652. doi: 10.1007/s10571-007-9181-x. - DOI - PMC - PubMed
    1. Chen W., Cheng X., Chen J., et al. Lycium barbarum polysaccharides prevent memory and neurogenesis impairments in scopolamine-treated rats. PLoS ONE. 2014;9(2) doi: 10.1371/journal.pone.0088076.e88076 - DOI - PMC - PubMed
    1. Kou L., Du M., Zhang C., et al. Polysaccharide purified from Lycium barbarum protects differentiated PC12 cells against L-Glu-induced toxicity via the mitochondria-associated pathway. Molecular Medicine Reports. 2017;16(4):5533–5540. doi: 10.3892/mmr.2017.7289. - DOI - PubMed

Publication types

LinkOut - more resources